HEALTHSTORY 532· JULY 4, 2026

DeGette's Loss Is a Mixed Bag for the Pharmaceutical Industry

The pharmaceutical industry is losing one of Capitol Hill's more informed Democratic voices. Democratic lawmaker DeGette has lost her seat, and STAT News's D.C. Diagnosis newsletter — which covers the politics and policy of health and…

NDNewsDialy Desk1 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 531Mercuria Energy Closes USD 3.84 Billion Multicurrency Revolving Credit Facilities NEXT STORY 533 →Pomerantz LLP Files Class Action Lawsuit Against Calix, Inc. (CALX), Urges Investors to Note Upcoming Deadlines

Keep reading

More from the desk.

16HEALTH

Autoimmune research pioneer Georg Schett co-founds his first biotech, choosing antibody therapies over CAR-T

Georg Schett, the German scientist who spent five years demonstrating that CAR-T therapy, a treatment that engineers a patient's own immune cells to target and eliminate the source of disease, can reset the immune system in autoimmune…

health2 MIN

32HEALTH

Splitting the MMR vaccine risks more missed doses and more sick children, history suggests

Separating the MMR vaccine into individual shots is likely to produce more missed doses and more sick kids. The MMR is a single injection covering measles, mumps, and rubella. It is now the target of a White House executive order

health2 MIN

34HEALTH

FDA Rejects ITM's Cancer Drug on Manufacturing Grounds, Blocking Novartis Rival

A manufacturing problem flagged by U.S. regulators has halted a radiopharmaceutical, a cancer therapy that works by delivering radioactive isotopes directly to tumor cells. The drug's maker, ITM Isotope Technologies Munich SE, had already…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk